Comparison of the effects of clonidine, rilmenidine, and guanfacine in the holeboard and elevated plus-maze
โ Scribed by Amanda L. Johnston; Elisabeth Koening-Berard; Teresa A. Cooper; Dr. Sandra E. File
- Book ID
- 102818602
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 677 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
โฆ Synopsis
Comparison of the effects of clonidine, rilmenidine, and guanfacine in the holeboard and elevated plusmaze. Drug Dev. Res. 15:405-414, 1988. The effects of clonidine, rilmenidine, and guanfacine were studied in the holeboard and elevated-plus maze tests in rats. In the holeboard test, clonidine had a profound effect on locomotor activity, significantly (P < 0.05) reducing this measure at all but one of the doses tested (0.005-0.25 mg/kg). In contrast, rilmenidine and guanfacine only markedly affected locomotor activity at 2.5 mg/kg or higher. The ED50's for locomotor activity were as follows: clonidine, 0.024 mg/kg; rilmenidine, 1.92 mgikg; and guanfacine, 1.65 mgikg. All three compounds also caused significant decreases in the number of head dips and time spent head-dipping. The effects of clonidine (0.005-0.25 mg/kg) and rilmenidine (0.25-1 0 mgikg) on the number of head-dips were significant (P < 0.01) at all doses and were dose dependent. The actions of guanfacine were similar, with all doses (0.1 25-5 mg/kg) differing significantly (P < 0.05) from the controls, except 1 mgikg. However, the time spent head-dipping was only decreased significantly (P < 0.05) by clonidine (0.005-0.25 mg/kg), rilmenidine (1, 5, and 10 mg/kg), and guanfacine (0.5-5.0 mgikg). In the elevated plus-maze, clonidine had no significant effect on the O/O number of entries made onto open arms, or the % of time spent on the open arms; rilrnenidine reduced the YO time spent on the
๐ SIMILAR VOLUMES
## Although noncompetitive NMDA receptor antagonists have shown an anxiolyticlike profile in several studies, such effects have not been observed consistently. Previous studies with ketamine, a noncompetitive NMDA antagonist, have employed only shock tests of anxiety based on conflict procedures. In